Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Symptom Burden and Quality of Life among Women with HER2(+) Metastatic Breast Cancer.

Mayer M, Lang K, Hurvitz S, Lalla D, Federico V, Brammer M, Menzin J, Tripathy D.

Breast J. 2015 Mar;21(2):208-10. doi: 10.1111/tbj.12374. Epub 2015 Feb 6. No abstract available.

PMID:
25655357
2.

Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data.

Menzin J, Preblick R, Friedman M, Menzin J, Frean M, Jacqueline Kwong W.

Hosp Pract (1995). 2014 Oct;42(4):59-74. doi: 10.3810/hp.2014.10.1143.

PMID:
25502130
3.

Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.

Lang K, Hao Y, Huang H, Lin I, Rogerio JW, Menzin J.

J Comp Eff Res. 2014 Sep;3(5):481-90. doi: 10.2217/cer.14.39.

PMID:
25350800
4.

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.

Huang H, Taylor DC, Carson RT, Sarocco P, Friedman M, Munsell M, Blum SI, Menzin J.

J Med Econ. 2014 Oct 21:1-31. [Epub ahead of print]

PMID:
25333331
5.

Economic impact of psychiatric relapse and recidivism among adults with schizophrenia recently released from incarceration: a Markov model analysis.

Lin I, Muser E, Munsell M, Benson C, Menzin J.

J Med Econ. 2015 Mar;18(3):219-29. doi: 10.3111/13696998.2014.971161. Epub 2014 Nov 26.

PMID:
25266814
6.

Use of blood products in patients with anticoagulant-related major bleeding: an analysis of inhospital outcomes.

Menzin J, Sussman M, Nichols C, Friedman M, Zbrozek A.

Am J Health Syst Pharm. 2014 Oct 1;71(19):1635-45. doi: 10.2146/ajhp130729.

PMID:
25225449
7.

Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.

Lang K, Patel AA, Munsell M, Bookhart BK, Mody SH, Schein JR, Menzin J.

J Thromb Thrombolysis. 2015 May;39(4):434-42. doi: 10.1007/s11239-014-1108-z.

PMID:
25079971
8.

Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.

Lang K, Bozkaya D, Patel AA, Macomson B, Nelson W, Owens G, Mody S, Schein J, Menzin J.

BMC Health Serv Res. 2014 Jul 28;14:329. doi: 10.1186/1472-6963-14-329.

9.
10.

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy.

Menzin J, Sussman M, Munsell M, Zbrozek A.

Clinicoecon Outcomes Res. 2014 Jun 10;6:297-302. doi: 10.2147/CEOR.S63200. eCollection 2014.

11.

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data.

Zilberberg MD, Shorr AF, Huang H, Chaudhari P, Paly VF, Menzin J.

BMC Infect Dis. 2014 Jun 5;14:310. doi: 10.1186/1471-2334-14-310.

12.

National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009.

Lang K, Huang H, Lee DW, Federico V, Menzin J.

BMC Med Imaging. 2013 Nov 26;13:40. doi: 10.1186/1471-2342-13-40.

13.

Impact of atrial fibrillation on stroke-related healthcare costs.

Sussman M, Menzin J, Lin I, Kwong WJ, Munsell M, Friedman M, Selim M.

J Am Heart Assoc. 2013 Nov 25;2(6):e000479. doi: 10.1161/JAHA.113.000479.

14.

Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia.

Lang K, Federico V, Muser E, Menzin J, Menzin J.

J Med Econ. 2013 Aug;16(8):997-1006. doi: 10.3111/13696998.2013.816310. Epub 2013 Jun 28.

PMID:
23777223
15.

Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.

Menzin J, Caon C, Nichols C, White LA, Friedman M, Pill MW.

J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S24-40. Review.

16.

Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.

Barnes CJ, Caon C, Foley JF, Friedman M, Menzin J, Nair KV, Nichols C, Olvey EL, Owens GM, Pill MW, Skrepnek GH, White LA, Zerkowski K.

J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S1-53. No abstract available.

17.

Failure of surgical and endovascular infrainguinal and iliac procedures in the management of peripheral arterial disease using data from electronic medical records.

Sussman M, Mallick R, Friedman M, Federico V, Josephs L, Vaitkus P, Menzin J.

J Vasc Interv Radiol. 2013 Mar;24(3):378-91, 391.e1-3. doi: 10.1016/j.jvir.2012.11.020. Epub 2013 Jan 26.

PMID:
23357568
18.

The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective.

Menzin J, White LA, Nichols C, Deniz B.

BMC Health Serv Res. 2012 Dec 15;12:459. doi: 10.1186/1472-6963-12-459.

19.

Quality-adjusted life years in cancer: pros, cons, and alternatives.

Woodward RM, Menzin J, Neumann PJ.

Eur J Cancer Care (Engl). 2013 Jan;22(1):12-9. doi: 10.1111/ecc.12006. Epub 2012 Sep 12.

PMID:
22966947
20.

Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation.

Menzin J, Marton JP, Menzin JA, Willke RJ, Woodward RM, Federico V.

BMC Med Res Methodol. 2012 Jun 25;12:87. doi: 10.1186/1471-2288-12-87.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk